These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Evaluation of TDP-43 proteinopathy and hippocampal sclerosis in relation to APOE ε4 haplotype status: a community-based cohort study. Yang HS; Yu L; White CC; Chibnik LB; Chhatwal JP; Sperling RA; Bennett DA; Schneider JA; De Jager PL Lancet Neurol; 2018 Sep; 17(9):773-781. PubMed ID: 30093249 [TBL] [Abstract][Full Text] [Related]
44. Mirza SS; Saeed U; Knight J; Ramirez J; Stuss DT; Keith J; Nestor SM; Yu D; Swardfager W; Rogaeva E; St George Hyslop P; Black SE; Masellis M; Neurology; 2019 Nov; 93(19):e1807-e1819. PubMed ID: 31575706 [TBL] [Abstract][Full Text] [Related]
45. Differential Associations of Apolipoprotein E ε4 Genotype With Attentional Abilities Across the Life Span of Individuals With Down Syndrome. D'Souza H; Mason L; Mok KY; Startin CM; Hamburg S; Hithersay R; Baksh RA; Hardy J; Strydom A; Thomas MSC; JAMA Netw Open; 2020 Sep; 3(9):e2018221. PubMed ID: 32986108 [TBL] [Abstract][Full Text] [Related]
46. Apolipoprotein E ε4 and cognitive function after surgery in middle-aged and elderly Danish twins. Dokkedal U; Wod M; Thinggaard M; Hansen TG; Rasmussen LS; Christensen K; Mengel-From J Eur J Anaesthesiol; 2020 Nov; 37(11):984-991. PubMed ID: 32618758 [TBL] [Abstract][Full Text] [Related]
47. APOE modifies the interaction of entorhinal cerebral blood flow and cortical thickness on memory function in cognitively normal older adults. Hays CC; Zlatar ZZ; Meloy MJ; Bondi MW; Gilbert PE; Liu TT; Helm JL; Wierenga CE Neuroimage; 2019 Nov; 202():116162. PubMed ID: 31493534 [TBL] [Abstract][Full Text] [Related]
48. Apolipoprotein E genotype and cerebrovascular alterations can influence conversion to dementia in patients with mild cognitive impairment. Viticchi G; Falsetti L; Vernieri F; Altamura C; Altavilla R; Luzzi S; Bartolini M; Provinciali L; Silvestrini M J Alzheimers Dis; 2014; 41(2):401-10. PubMed ID: 24625799 [TBL] [Abstract][Full Text] [Related]
51. Lower cognitive performance of older football players possessing apolipoprotein E epsilon4. Kutner KC; Erlanger DM; Tsai J; Jordan B; Relkin NR Neurosurgery; 2000 Sep; 47(3):651-7; discussion 657-8. PubMed ID: 10981753 [TBL] [Abstract][Full Text] [Related]
52. APOE genotype, hippocampus, and cognitive markers of Alzheimer's disease in American Indians: Data from the Strong Heart Study. Suchy-Dicey A; Howard B; Longstreth WT; Reiman EM; Buchwald D Alzheimers Dement; 2022 Dec; 18(12):2518-2526. PubMed ID: 35142437 [TBL] [Abstract][Full Text] [Related]
53. Lack of reliable evidence for a distinctive ε4-related cognitive phenotype that is independent from clinical diagnostic status: findings from the Australian Imaging, Biomarkers and Lifestyle Study. Foster JK; Albrecht MA; Savage G; Lautenschlager NT; Ellis KA; Maruff P; Szoeke C; Taddei K; Martins R; Masters CL; Ames D; Brain; 2013 Jul; 136(Pt 7):2201-16. PubMed ID: 23737466 [TBL] [Abstract][Full Text] [Related]
58. Effect of Apolipoprotein E ɛ4 Carrier Status on Cognitive Response to Acetylcholinesterase Inhibitors in Patients with Alzheimer's Disease: A Systematic Review and Meta-Analysis. Cheng YC; Huang YC; Liu HC Dement Geriatr Cogn Disord; 2018; 45(5-6):335-352. PubMed ID: 30041236 [TBL] [Abstract][Full Text] [Related]
59. The Elusive Nature of APOE ε4 in Mid-adulthood: Understanding the Cognitive Profile. Lancaster C; Tabet N; Rusted J J Int Neuropsychol Soc; 2017 Mar; 23(3):239-253. PubMed ID: 28059047 [TBL] [Abstract][Full Text] [Related]
60. Gene-environment interactions: lifetime cognitive activity, APOE genotype, and β-amyloid burden. Wirth M; Villeneuve S; La Joie R; Marks SM; Jagust WJ J Neurosci; 2014 Jun; 34(25):8612-7. PubMed ID: 24948815 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]